Accumulating evidences of underlining pathogenesis of sepsis have contributed to the therapeutic strategy for sepsis. Not only endotoxin and cytokine, but also signal transduction through Toll-like receptors could be a strategic target for the management of sepsis. Blood purification therapy including polymyxin B-immobilized hemoperfusion cartridge and continuous hemodiafiltration has shown the beneficial effect on patients with sepsis in Japan. Although they were initially designed to remove endotoxin and cytokines respectively, they might eliminate unexpected mediators responsible for sepsis. Further elucidation of mechanism and randomized controlled studies are needed to establish the role of blood purification therapy in sepsis.
Blood purification therapy for sepsis. Publishing Authors By Initials
Blood purification therapy for sepsis. Journal Published:
PUBLICATION TYPE: Journal Article
Journal: Transfusion and apheresis science : official journ
VOLUME: 35
Page Numbers: 245-51
Journal Abbreviation: Transfus. Apher. Sci.
ISSN: 1473-0502
DAY: 15
MONTH: 11
YEAR: 2006
Blood purification therapy for sepsis. Information
Number of References:
LANGUAGE: eng
NlmUniqueID: 101095653
Blood purification therapy for sepsis. Keywords Mesh Terms:
KEYWORDS:
MESH TERMS:
Chemical & Substance for Abstract: Blood purification therapy for sepsis. Information
Substance Name:
Registry Number:
Grant and Affiliation Information for Blood purification therapy for sepsis.
AFFILIATION: Department of Surgery, Sapporo Hokuyu Hospital, Research Institute for Artificial Organs, Transplantation and Gene Therapy, 6-6-5-1, Higashi Sapporo, Shiroishi-Ku, Sapporo, Hokkaido 003-0006, Japan.
Country: England
AGENCY:
GRANT:
ACRONYM:
MEDLINETA: Transfus Apher Sci
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
Blood purification therapy for sepsis Related Publications